Category: 22nd
-
Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lun
•
The first scientific presentation of previously announced data from Cohort 1 of an ongoing Phase 1b clinical trial evaluating low-dose LTI-03 (2.5 mg twice daily) in IPF, confirms positive trends in seven of the eight biomarkers evaluated, suggesting to a potential therapeutic effect Enrollment in the second cohort evaluating high-dose…
-
Market Outlook for the Week of 22nd – 26th July
•
The foreign exchange calendar is light on events scheduled for Monday and Tuesday. On Tuesday, traders will be watching the US existing home sales data and the Richmond manufacturing index. On Wednesday, focus shifts to the spot services PMI and spot manufacturing PMI for Australia, Japan, the eurozone, the UK…